Search for: "BIOTECH, INC."
Results 41 - 60
of 1,249
Sort by Relevance
|
Sort by Date
11 Nov 2022, 9:40 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
10 Nov 2022, 3:58 am
These include AMD, Microsoft, Intel, Square (Block, Inc.), Meta, NVIDIA, PayPal, IBM, and very recently, JP Morgan Chase. [read post]
26 Sep 2022, 4:49 am
Although the focus here is biotech, the same arguments are brewing with regard to AI-assisted inventions. [read post]
10 Aug 2022, 6:50 pm
(Goldstein, New York Times).Modern SPACs changed focus to companies disrupting industries like consumer, technology, and biotech markets. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
19 Jul 2022, 2:59 pm
BioMimetic Therapeutics, Inc., 2013 WL 139521, at *13-14 (M.D. [read post]
18 Jul 2022, 1:48 pm
Natera, Inc., — 4th — (Fed. [read post]
19 Jun 2022, 1:40 pm
’ ” (Cel-Tech Communications, Inc. v. [read post]
2 May 2022, 8:25 pm
The acquisition of Wilmington-based PPD, Inc. [read post]
18 Apr 2022, 12:15 pm
Third, from "U2 disbands: In a crushing step back, TG retracts FDA request for combo therapy due to death risk", a Fierce Biotech article with some contextual facts concerning the April 2022 Ukoniq drug recall: Ukoniq’s fall from grace comes less than 15 months after it first hit the market through the FDA’s accelerated approval pathway to treat two types of blood cancer. [read post]
8 Apr 2022, 2:05 am
(Boston, MA) Commercial Counsel, Wayfair Inc. [read post]
21 Mar 2022, 6:35 am
The claim further alleges the firm unsuitably invested its clients in the following high-risk pharmaceutical and biotech investments, among others: Acadia Pharmaceutical, Inc. [read post]
17 Mar 2022, 2:32 pm
Janssen Biotech, Inc., 759 F.3d 1285, 1300–01 (Fed. [read post]
17 Mar 2022, 10:54 am
” Intel and Xilinx combined to cancel a number of litigation-funded chip patents from Arbor Global Strategies and FG SRC LLC [the latter funded by Freeman Capital Partners]; a number of Fortress-funded subsidiaries were challenged; another 29 IP Edge subsidiary suits; some interesting pharmaceutical action; and companies WebRoot and OpenText, inc. have launched a new assertion campaign against Trend Micro, Kapersky Labs, CrowdStrike, and Sophos on cybersecurity products. [read post]
11 Mar 2022, 6:01 am
Llewellyn, Fenwick & West LLP, on Sunday, March 6, 2022 Tags: Biotech companies, Board composition, Boards of Directors, Disclosure, Diversity, ESG, Human capital, SASB SEC Proposes Amendments to Schedules 13D and 13G Posted by Curtis A. [read post]
